EMA Authorised: Fendrix (hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

Fendrix has been authorised by the EMA for use in its hepatitis B immunization program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Fendrix

Snippet

Status: Authorised. Therapeutic area: Hepatitis B;Immunization. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 09/07/2026